Detalhe da pesquisa
1.
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index.
Eur J Nucl Med Mol Imaging;
50(5): 1510-1520, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36650356
2.
Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
Gynecol Oncol;
167(2): 152-158, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36182533
3.
From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups?
Gynecol Oncol;
163(2): 281-288, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34503847
4.
Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment.
Eur J Nucl Med Mol Imaging;
46(5): 1164-1174, 2019 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30637500
5.
A randomised trial of [18F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocol.
BJUI Compass;
4(5): 513-522, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37636207
6.
Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer.
Diagnostics (Basel);
10(12)2020 Nov 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33260766
7.
Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer.
Diagnostics (Basel);
10(12)2020 Nov 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33255442
8.
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond.
Cancers (Basel);
11(8)2019 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31443324